Kawai K,Gebremeskel BG,Acosta CJ.Systematic review of incidence and complications of herpes zoster:towards a global perspective[J].BMJ Open,2014,4(6):e004833.
[5]
Takao Y,Miyazaki Y,Okeda M,et al.Incidences of herpes zoster and postherpetic neuralgia in japanese adults aged 50years and older from a community-based prospective cohort study:The SHEZ Study[J].J Epidemiol,2015,25(10):617-625.
[6]
Forbes HJ,Thomas SL,Smeeth L,et al.A systematic review and meta-analysis of risk factors for postherpetic neuralgia[J].Pain,2016,157(1):30-54.
[7]
Markley HG,Dunteman ED,Kareht S,et al.Realworld experience with once-daily gabapentin for the treatment of postherpetic neuralgia(PHN)[J].Clin J Pain,2015,31(1):58-65.
[8]
Pinchinat S,Cebrian-Cuenca AM,Bricout H,et al.Similar herpes zoster incidence across Europe:results from a systematic literature review[J].BMC Infect Dis,2013,13:170.
[9]
Schneider JS,Gollomp SM,Sendek S,et al.A randomized,controlled,delayed start trial of GM1ganglioside in treated Parkinson's disease patients[J].J Neurol Sci,2013,324(1-2):140-148.
